The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy

References

• Siegel RL, Miller KD, Jemal A. 2018. Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. doi:10.3322/caac.21442.
   PubMed Web of Science ®Google Scholar
• Chan JK, Chow S, Bhowmik S, Mann A, Kapp DS, Coleman RL. 2018. Metastatic gynecologic malignancies: advances in treatment and management. Clin Exp Metastasis. 35:521–533. doi:10.1007/s10585-018-9889-7.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. 2015. Global cancer statistics, 2012. CA Cancer J Clin. 65(2):87–108. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Crafton SM, Salani R. 2016. Beyond chemotherapy: an overview and review of targeted therapy in cervical cancer. Clin Ther. 38(3):449–458. doi:10.1016/j.clinthera.2016.02.007.
   PubMed Web of Science ®Google Scholar
• Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, Benda J, Cella D. 2009. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a gynecologic oncology group study. J Clin Oncol. 27:4649–4655. doi:10.1200/JCO.2009.21.8909.
   PubMed Web of Science ®Google Scholar
• Zhang W, Xing L. 2013. RNAi gene therapy of SiHa cells via targeting human TERT induces growth inhibition and enhances radiosensitivity. Int J Oncol. 43:1228–1234. doi:10.3892/ijo.2013.2051.
   PubMed Web of Science ®Google Scholar
• Simons M, Raposo G. 2009. Exosomes–vesicular carriers for intercellular communication. Curr Opin Cell Biol. 21:575–581. doi:10.1016/j.ceb.2009.03.007.
   PubMed Web of Science ®Google Scholar
• Borges FT, Reis LA, Schor N. 2013. Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res = Revista Brasileira De Pesquisas Medicas E Biologicas. 46:824–830. doi:10.1590/1414-431X20132964.
   PubMed Web of Science ®Google Scholar
• Ronquist G, Brody I. The prostasome: its secretion and function in man. Biochim Biophys Acta. 1985;822:203–218.
   PubMed Web of Science ®Google Scholar
• Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 2005;17:879–887.
   PubMed Web of Science ®Google Scholar
• Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A. 2004;101:13368–13373.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Miura Y, Harazono A, Kanai-Azuma M, Akimoto Y, Kawakami H, Yamaguchi T, Toda T, Endo T, Tsubuki M, et al. Proteomic analysis of two types of exosomes in human whole saliva. Biol Pharm Bull. 2011;34:13–23.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. 2013. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 200:373–383. doi:10.1083/jcb.201211138.
   PubMed Web of Science ®Google Scholar
• Vader P, Mol EA, Pasterkamp G, Schiffelers RM. 2016. Extracellular vesicles for drug delivery. Adv Drug Deliv Rev. 106:148–156. doi:10.1016/j.addr.2016.02.006.
   PubMed Web of Science ®Google Scholar
• Escudier B, Dorval T, Chaput N, André F, Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med. 2005;3:10.
   PubMed Web of Science ®Google Scholar
• Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med. 2005;3:9.
   PubMed Web of Science ®Google Scholar
• Xiong J, Du Q, Liang Z. 2010. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene. 29:4980–4988. doi:10.1038/onc.2010.241.
   PubMed Web of Science ®Google Scholar
• Cole MD, McMahon SB. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene. 1999;18:2916–2924.
   PubMed Web of Science ®Google Scholar
• Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene. 1999;18:3004–3016.
   PubMed Web of Science ®Google Scholar
• Meyer N, Penn LZ. 2008. Reflecting on 25 years with MYC. Nat Rev Cancer. 8:976–990. doi:10.1038/nrc2231.
   PubMed Web of Science ®Google Scholar
• Wang YW, Chang HS, Lin CH, Yu WC. HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity. Int J Biochem Cell Biol. 2007;39:402–412.
   PubMed Web of Science ®Google Scholar
• Bourhis J1, Le MG, Barrois M, Gerbaulet A, Jeannel D, Duvillard P, Le Doussal V, Chassagne D, Riou G. Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix. J Clin Oncol. 1990;8:1789–1796.
   PubMed Web of Science ®Google Scholar
• Gebert LFR, MacRae IJ. 2019. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 20:21–37. doi:10.1038/s41580-018-0045-7.
   PubMed Web of Science ®Google Scholar
• Zhou X, Natino D, Zhai X, Gao Z, He X. 2018. MicroRNA22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells. Mol Med Rep. 17:7209–7217. doi:10.3892/mmr.2018.8790.
   PubMed Web of Science ®Google Scholar
• Xia SS, Zhang GJ, Liu ZL, Tian HP, He Y, Meng CY, Li LF, Wang ZW, Zhou T. 2017. MicroRNA-22 suppresses the growth, migration and invasion of colorectal cancer cells through a Sp1 negative feedback loop. Oncotarget. 8:36266–36278. doi:10.18632/oncotarget.16742.
   PubMedGoogle Scholar
• Qiao DD, Yang J, Lei XF, Mi GL, Li SL, Li K, Xu CQ, Yang HL. Expression of microRNA-122 and microRNA-22 in HBV-related liver cancer and the correlation with clinical features. Eur Rev Med Pharmacol Sci. 2017;21:742–747.
   PubMed Web of Science ®Google Scholar
• Chen J, Wu FX, Luo HL, Liu JJ, Luo T, Bai T, Li LQ, Fan XH. Berberine upregulates miR-22-3p to suppress hepatocellular carcinoma cell proliferation by targeting Sp1. Am J Transl Res. 2016;8:4932–4941.
   PubMed Web of Science ®Google Scholar
• Xin M, Qiao Z, Li J, Liu J, Song S, Zhao X, Miao P, Tang T, Wang L, Liu W, et al. miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer. Oncotarget. 2016;7:44252–44265.
   PubMedGoogle Scholar
• Zhang L, Chen B, Ding D. Decreased microRNA-22 is associated with poor prognosis in cervical cancer. Int J Clin Exp Pathol. 2017;10:9515–9520.
   PubMed Web of Science ®Google Scholar
• Satra M, Tsougos I, Papanikolaou V, Theodorou K, Kappas C, Tsezou A. Correlation between radiation-induced telomerase activity and human telomerase reverse transcriptase mRNA expression in HeLa cells. Int J Radiat Biol. 2006;82:401–409.
   PubMed Web of Science ®Google Scholar
• Qi DL, Ohhira T, Fujisaki C, Inoue T, Ohta T, Osaki M, Ohshiro E, Seko T, Aoki S, Oshimura M, et al. 2011. Identification of PITX1 as a TERT suppressor gene located on human chromosome 5. Mol Cell Biol. 31:1624–1636. doi:10.1128/MCB.00470–10.
   PubMed Web of Science ®Google Scholar
• Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, et al. 2013. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 31:185–191. doi:10.1038/mt.2012.180.
   Google Scholar
• Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, et al. 2017. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways. Oncol Rep. 37:3189–3200. doi:10.3892/or.2017.5583.
   PubMed Web of Science ®Google Scholar
• Ono YJ, Hayashi M, Tanabe A, Hayashi A, Kanemura M, Terai Y, Ohmichi M. 2015. Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial-to-mesenchymal transition in the peritoneum. Am J Physiol Endocrinol Metab. 308:E950–E959. doi:10.1152/ajpendo.00573.2014.
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 9:671–675. doi:10.1038/nmeth.2089.
   PubMed Web of Science ®Google Scholar
• Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nature Protoc. 1:2315–2319. doi:10.1038/nprot.2006.339.
   PubMed Web of Science ®Google Scholar
• Bahmad HF, Cheaito K, Chalhoub RM, Hadadeh O, Monzer A, Ballout F, El-Hajj A, Mukherji D, Liu YN, Daoud G, et al. 2018. Spere-formation assay: theree-dimensional in vitro culturing of prostate cancer stem/progenitor sphere-forming cells. Front Oncol. 8:347. doi:10.3389/fonc.2018.00347.
   PubMed Web of Science ®Google Scholar
• Bodgi L, Bahmad HF, Araji T, Al Choboq J, Bou-Gharios J, Cheaito K, Zeidan YH, Eid T, Geara F, Abou-Kheir W. 2019. Assessing radiosensitivity of bladder cancer in vitro: A 2D vs. 3D approach. Front Oncol. 9:153. doi:10.3389/fonc.2019.00153.
   PubMed Web of Science ®Google Scholar
• Sakamuro D, Prendergast GC. New Myc-interacting proteins: a second Myc network emerges. Oncogene. 1999;18:2942–2954.
   PubMed Web of Science ®Google Scholar
• Liu C, Gao H, Lv P, Liu J, Liu G. 2017. Extracellular vesicles as an efficient nanoplatform for the delivery of the therapeutics. Hum Vaccin Immunother. 13:2678–2687. doi:10.1080/21645515.2017.1363935.
   PubMed Web of Science ®Google Scholar
• Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, Osobamiro O, Shu W, Jiang F, Chopp M. 2013. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett. 335:201–204. doi:10.1016/j.canlet.2013.02.019.
   PubMed Web of Science ®Google Scholar
• Bigagli E, Luceri C, Gausti D, Cinci L. 2016. Exosomes secreted from human colon cancer cells influence the adhesion of neighboring metastatic cells: role of microRNA-210. Cancer Biol Ther. 17:1062–1069. doi:10.1080/15384047.2016.1219815.
   PubMed Web of Science ®Google Scholar
• de Araujo Farias V, O’Valle F, Serrano-Saenz S, Anderson P, Andrés E, López-Peñalver J, Tovar I, Nieto A, Santos A, Martín F, et al. 2018. Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci. Mol Cancer. 17:122. doi:10.1186/s12943-018-0867-0.
   PubMed Web of Science ®Google Scholar
• Ram R, Uziel O, Eldan O, Fenig E, Beery E, Lichtenberg S, Nordenberg Y, Lahav M. Ionizing radiation in mammals. J Exp Med. 2000;192:1625–1636.
   PubMed Web of Science ®Google Scholar
• Moreno-Acosta P, Vallard A, Carrilo S, Gamboa O, Romero-Rojas A, Molano M, Acosta J, Mayorga D, Rancoule C, Garcia MA, et al. 2017. Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma. Radiat Oncol. 12:120. doi:10.1186/s13014-017-0856-2.
   PubMed Web of Science ®Google Scholar
• Ling X, Yang W, Zou P, Zhang G, Wang Z, Zhang X, Chen H, Peng K, Han F, Liu J, et al. 2018. TERT regulates telomere-related senescence and apoptosis through DNA damage response in male germ cells exposed to BPDE in vitro and to B[a]P in vivo. Environ Pollut. 235:836–849. doi:10.1016/j.envpol.2017.12.099.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yu L, Dai G, Xia K, Liu G, Song Q, Tao C, Gao T, Guo W. 2017. Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells. Sci Rep. 7:7070. doi:10.1038/s41598-017-07204-w.
   PubMed Web of Science ®Google Scholar
• Wang T, Xue Y, Wang M, Sun Q. 2012. Silencing of the hTERT gene through RNA interference induces apoptosis via bax/bcl-2 in human glioma cells. Oncol Rep. 28:1153–1158. doi:10.3892/or.2012.1952.
   PubMed Web of Science ®Google Scholar